Skip to main content

Table 3 Average prevalences of moderate- and high-intensity infections infections in women of reproductive age

From: Deworming women of reproductive age during adolescence and pregnancy: what is the impact on morbidity from soil-transmitted helminths infection?

Modela Age period (years) SB only, mean (95% credible interval) SB + WRA, mean (95% credible interval) % Reduction, mean (95% credible interval)b P value
ICL 15–50 3.42 × 10−4 (0–1.43 × 10−3) 5.23 × 10−5 (0–4.75 × 10−4) 41 (0–100) 9.33 × 10−7
ICL 15–19 1.97 × 10−3 (0–0.01) 3.33 × 10−4 (0–3.33 × 10−3) 37 (0–100) 1.27 × 10−6
ICL 20–50 0 (0–0) 0 (0–0) 0 (0–0) NA
EMC 15–50 4.56 (4.11–4.97) 3.51 (3.13–3.85) 23.0 (20.5–25.7) < 2.2 × 10−16
EMC 15–19 3.72 (3.29–4.11) 1.75 (1.50–2.01) 53.0 (48.0–58.6) < 2.2 × 10−16
EMC 20–50 4.70 (4.25–5.10) 3.81 (3.41–4.17) 19.0 (16.2–21.9) < 2.2 × 10−16
  1. Values in table are presented as the mean prevalence (%)
  2. aModerate baseline prevalence (20–50%), semi-annual SB treatment. The FoI inputted into the cohort model was extracted from ICL and EMC fully stochastic individual-based models with ongoing semi-annual SB treatment, i.e. FoI decreased over time. In the ICL model prevalences of M&HI infections in WRA are below 1%. Therefore, the reduction in the prevalence of M&HI infections in absolute numbers is negligible and the uncertainty large
  3. bThe relative reduction is only calculated from time points where the prevalence of M&HI infections in simulations with the old treatment strategy (SB only) is > 0. All time points were used in the statistical comparison